Comprehensive molecular profiles of low-grade serous ovarian carcinoma

被引：0
|
作者：
ElNaggar, A. C. [1 ]
Robins, D. B. [1 ]
Arguello, D. [2 ]
Ulm, M. A. [1 ]
Mantia-Smaldone, G. M. [3 ]
Chu, C. [3 ]
Winer, I. [4 ]
Holloway, R. W. [5 ]
Krivak, T. C. [6 ]
Jones, N. L. [7 ]
Galvan-Turner, V. [8 ]
Herzog, T. J. [9 ]
Brown, J. [10 ]
机构：
[1] Univ Tennessee, West Canc Ctr, Memphis, TN USA
[2] Caris Life Sci, Irving, TX USA
[3] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Wayne State Univ, Detroit, MI USA
[5] Florida Hosp Canc Inst, Orlando, FL USA
[6] Western Penn Hosp, Pittsburgh, PA 15224 USA
[7] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA
[8] WVU Healthcare, Morgantown, WV USA
[9] UC Hlth Barrett Canc Ctr, Cincinnati, OH USA
[10] Carolinas Med Ctr, Levine Canc Inst, Charlotte, NC 28203 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1213
引用
收藏
页码：60 / 61
页数：3
相关论文
共 50 条
  • [21] Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
    Dey, Puja
    Nakayama, Kentaro
    Razia, Sultana
    Ishikawa, Masako
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Kanno, Kosuke
    Sato, Seiya
    Kiyono, Tohru
    Kyo, Satoru
    CANCERS, 2022, 14 (06)
  • [22] Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma: Report of a Series of Cases of an Unusual Phenomenon
    Boyd, Clinton
    McCluggage, W. Glenn
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 368 - 375
  • [23] Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium
    Qiu, Chunping
    Lu, Nan
    Wang, Xiao
    Zhang, Qing
    Yuan, Cunzhong
    Yan, Shi
    Dongol, Samina
    Li, Yingwei
    Sun, Xiaomei
    Sun, Chenggong
    Zhang, Zhiwei
    Zheng, Wenxin
    Kong, Beihua
    GYNECOLOGIC ONCOLOGY, 2017, 147 (03) : 634 - 641
  • [24] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [25] Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
    Fernandez, Marta Llaurado
    Dawson, Amy
    Kim, Hannah
    Lam, Nicole
    Russell, Holly
    Bruce, Maegan
    Bittner, Madison
    Hoenisch, Joshua
    Scott, Stephanie A.
    Talhouk, Aline
    Chiu, Derek
    Provencher, Diane
    Nourmoussavi, Melica
    DiMattia, Gabriel
    Lee, Cheng-Han
    Gilks, C. Blake
    Kobel, Martin
    Carey, Mark S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 12 - 20
  • [26] Skin Metastasis of Low-Grade Ovarian Serous Carcinoma: A Case Report
    Ching, Lauren M.
    Tran, Benjamin A.
    Russomanno, Kristen L.
    Cardis, Michael A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [27] Disparities in care among patients with low-grade serous ovarian carcinoma
    Siemon, J.
    Galli, J.
    Slomovitz, B.
    Schlumbrecht, M.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 46 - 54
  • [28] Survival outcomes for patients with recurrent low-grade serous ovarian carcinoma
    Yazigi, A.
    Ray-Coquard, I. L.
    Pujade-Lauraine, E.
    Lecuru, F.
    Bonsang-Kitzis, H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 93 - 94
  • [29] Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma
    Rose, Peter G.
    Radeva, Milena
    Michener, Chad M.
    Link, Nicholas
    Adbul-Karim, Fadi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 907 - 911
  • [30] Low-grade serous ovarian carcinoma is a rare histological subtype in Japan
    Iwahashi, Hideki
    Miyamoto, Morikazu
    Sakamoto, Takahiro
    Ishibashi, Hiroki
    Kakimoto, Soichiro
    Matsuura, Hiroko
    Tsuda, Hitoshi
    Takano, Masashi
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (06) : 1004 - 1009
12345